Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples



► Subscribe to EMAT database


Sectors covered by our analysts


► Studies & indices published by Epsilon Research: Register to receive (free) publications updates


► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Transaction Multiples for the Valuation of Private Companies

Eurazeo / Horus Pharma

No EMAT : 109015
Announced Date : 14/03/2022
Type : LBO (Leverage Buy Out)
Deal Value : Yes
Acquirer : Eurazeo

Target : Horus Pharma
Country : Alpes-Maritimes
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
  • Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Founded in 2003, Horus Pharma is an ophthalmology pharmaceuticals producer in France . > Sells a wide range of more than 40 medicines, medical devices and food supplements designed to facilitate eye...

Transaction multiples available
Gross Profit
P/E Price
to Book
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 118
  • Number of EMAT Reports / sub-sector « Food Complements » = 107
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
22/02/2022 Airbus, Safran and Tikehau ACE Capital AD Aubert & Duval France ** 111718
30/09/2004 NWD Group Plc Clinic Group Ltd United Kingdom ** 10235

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report